Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Ecopetrol
EC
Taylor Morrison Home
TMHC
KB Home
KBH
US Stock MarketDetailed Quotes
CRBU Caribou Biosciences
- 0.939
- -0.050-5.02%
Close Mar 28 16:00 ET
- 0.925
- -0.014-1.50%
Post 19:02 ET
87.34MMarket Cap-0.57P/E (TTM)
1.000High0.925Low644.46KVolume0.993Open0.989Pre Close610.91KTurnover0.77%Turnover RatioLossP/E (Static)93.00MShares5.15052wk High0.35P/B78.83MFloat Cap0.88052wk Low--Dividend TTM83.94MShs Float32.645Historical High--Div YieldTTM7.57%Amplitude0.880Historical Low0.947Avg Price1Lot Size
About Caribou Biosciences Company
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Company Profile
SymbolCRBU
Company NameCaribou Biosciences
Listing DateJul 23, 2021
Issue Price16.00
Founded2011
CEODr. Rachel Haurwitz, PhD
MarketNASDAQ
Employees147
Fiscal Year Ends12-31
Address2929 7th Street,Suite 105
CityBerkeley
ProvinceCalifornia
CountryUnited States of America
Zip Code94710
Phone1-510-982-6030
Websitehttp://www.cariboubio.com
Company Executives
- Name
- Position
- Salary
- Dr. Rachel Haurwitz, PhD
- President, Chief Executive Officer and Director
- 3.12M
- Sriram Ryali, M.B.A.
- Chief Financial Officer and Principal Accounting Officer
- --
- Ruhi Ahmad Khan, M.B.A.
- Chief Business Officer
- --
- Barbara G. McClung, J.D.
- Chief Legal Officer and Corporate Secretary
- 1.22M
- Tim Kelly, M.B.A.
- Chief Technology Officer
- --
- Dr. Tina Albertson, M.D.,PhD
- Chief Medical Officer
- --
- Dr. Steven B. Kanner, PhD
- Chief Scientific Officer
- 1.22M
- Ryan Fischesser
- Vice President, Finance and Controller
- --
- Andrew L. Guggenhime
- Chairman of the Board
- 202.74K
- Ran Zheng
- Independent Director
- 157.20K
- David L. Johnson, C.P.A.
- Independent Director
- 143.85K
- Dr. Scott Braunstein, M.D.
- Independent Director
- 155.86K
- Dr. Natalie Sacks
- Independent Director
- 136.99K
- Dr. Nancy C. Whiting, Pharm.D.
- Independent Director
- 140.62K
- Dr. Dara Richardson-Heron
- Independent Director
- 141.93K
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
